IFNG and graft versus host disease: EVs derived from MSCs modified with interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and IL-1β increased the immunosuppressive effects on activated T cells, increased the induction of Tregs, decreased the scores and prolonged the survival time in a mouse GVHD model.87